DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
KW-2450
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms
Insulin-like growth factor I receptor inhibitor
KW-2450
×
Maximum Phase:
1
First Approval:
None
UNII:
2TRH1EX32K
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CESIUM CS-131
1
Small molecule
Investigational
Unknown
Unknown
Head and Neck Neoplasms; Carcinoma, Squamous Cell
Unknown
CESIUM CS-131
×
Maximum Phase:
1
First Approval:
None
UNII:
BKV67W3IO8
Molecule Type:
Small molecule
Molecular Formula:
Cs
Molecular Weight:
130.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ATU027
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ATU027
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LESOFAVUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
LESOFAVUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
J8O0SI025W
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PRT-2607
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase SYK inhibitor
PRT-2607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INULINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
INULINE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C32H46N2O8
Molecular Weight:
586.73
AlogP:
1.72
PSA:
132.94
HBD:
3.0
HBA:
#RotB:
8.0
Source:
GS-441524
1
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
GS-441524
×
Maximum Phase:
1
First Approval:
None
UNII:
1BQK176DT6
Molecule Type:
Small molecule
Molecular Formula:
C12H13N5O4
Molecular Weight:
291.27
AlogP:
-1.86
PSA:
149.92
HBD:
4.0
HBA:
#RotB:
2.0
Source:
SCIO-323
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
SCIO-323
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C27H30FN3O4
Molecular Weight:
479.55
AlogP:
3.69
PSA:
71.85
HBD:
0.0
HBA:
#RotB:
6.0
Source:
AV-380
1
Unknown
Investigational
Unknown
Unknown
Cachexia
Unknown
AV-380
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PALOMID-529
1
Small molecule
Investigational
Unknown
Unknown
Macular Degeneration
Serine/threonine-protein kinase mTOR inhibitor
PALOMID-529
×
Maximum Phase:
1
First Approval:
None
UNII:
XV9409EWG4
Molecule Type:
Small molecule
Molecular Formula:
C24H22O6
Molecular Weight:
406.43
AlogP:
4.6
PSA:
78.13
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ARDENERMIN
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
ARDENERMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9B1I11GZRB
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SYM-023
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SYM-023
×
Maximum Phase:
1
First Approval:
None
UNII:
9GEU9XHE20
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GANULAMERAN
1
Unknown
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
GANULAMERAN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-9977
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Heart Failure; Kidney Diseases
Mineralocorticoid receptor modulator
AZD-9977
×
Maximum Phase:
1
First Approval:
None
UNII:
6C9UKZ0CYE
Molecule Type:
Small molecule
Molecular Formula:
C20H18FN3O5
Molecular Weight:
399.38
AlogP:
1.7
PSA:
96.97
HBD:
2.0
HBA:
#RotB:
3.0
Source:
XL-418
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Ribosomal protein S6 kinase (P70S6K) inhibitor
XL-418
×
Maximum Phase:
1
First Approval:
None
UNII:
OLJ18SRI8A
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZB-716
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
ZB-716
×
Maximum Phase:
1
First Approval:
None
UNII:
E35ZN95LMT
Molecule Type:
Small molecule
Molecular Formula:
C32H48BF5O4S
Molecular Weight:
634.6
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ARQ-736
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase B-raf inhibitor
ARQ-736
×
Maximum Phase:
1
First Approval:
None
UNII:
Y2H4S74Y8U
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-8776
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MK-8776
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAROVASERTIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DAROVASERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
E0YF0M8O09
Molecule Type:
Small molecule
Molecular Formula:
C22H23F3N8O
Molecular Weight:
472.48
AlogP:
3.1
PSA:
135.94
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ROCAKINOGENE SIFUPLASMID
1
Gene
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Glioblastoma; Hemorrhagic Fever, Ebola; HIV Infections; Neoplasms; Urinary Bladder Neoplasms
Unknown
ROCAKINOGENE SIFUPLASMID
×
Maximum Phase:
1
First Approval:
None
UNII:
91JHE0ANN8
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEPOTINIB HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung
Hepatocyte growth factor receptor inhibitor
TEPOTINIB HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
VY5YX2TQ1F
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClN6O3
Molecular Weight:
547.06
AlogP:
4.01
PSA:
96.93
HBD:
0.0
HBA:
#RotB:
7.0
Source:
LS 11
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LS 11
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZOYLPHENYLUREA
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
BENZOYLPHENYLUREA
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.26
AlogP:
2.41
PSA:
63.4
HBD:
1.0
HBA:
#RotB:
2.0
Source:
STRO-001
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
STRO-001
×
Maximum Phase:
1
First Approval:
None
UNII:
0D8BWL78LD
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GCC-4401C
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GCC-4401C
×
Maximum Phase:
1
First Approval:
None
UNII:
I636054KKA
Molecule Type:
Small molecule
Molecular Formula:
C18H18ClN5O3S
Molecular Weight:
419.89
AlogP:
2.51
PSA:
86.27
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NNZ-2591
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NNZ-2591
×
Maximum Phase:
1
First Approval:
None
UNII:
2T1HU6069S
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O2
Molecular Weight:
194.23
AlogP:
0.05
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CARBACYCLIC PHOSPHATIDIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Unknown
CARBACYCLIC PHOSPHATIDIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
OXV962AR86
Molecule Type:
Small molecule
Molecular Formula:
C22H41O5P
Molecular Weight:
416.54
AlogP:
6.4
PSA:
72.83
HBD:
1.0
HBA:
#RotB:
17.0
Source:
BQ 788
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases
Unknown
BQ 788
×
Maximum Phase:
1
First Approval:
None
UNII:
6MB0YNA8DJ
Molecule Type:
Small molecule
Molecular Formula:
C34H51N5O7
Molecular Weight:
641.81
AlogP:
4.82
PSA:
159.07
HBD:
4.0
HBA:
#RotB:
12.0
Source:
ANX-042
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
ANX-042
×
Maximum Phase:
1
First Approval:
None
UNII:
ZV0MCR055T
Molecule Type:
Protein
Molecular Formula:
C189H312N58O53S4
Molecular Weight:
4373.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DI-LEU16-IL2
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Follicular
Unknown
DI-LEU16-IL2
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VELSECORAT
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Asthma
Unknown
VELSECORAT
×
Maximum Phase:
1
First Approval:
None
UNII:
P30N0911C2
Molecule Type:
Small molecule
Molecular Formula:
C32H32F2N4O6
Molecular Weight:
606.63
AlogP:
4.6
PSA:
112.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ST1535
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A2a receptor antagonist
ST1535
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H16N8
Molecular Weight:
272.32
AlogP:
0.87
PSA:
100.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AN-2718
1
Small molecule
Investigational
Unknown
Unknown
Tinea Pedis
Unknown
AN-2718
×
Maximum Phase:
1
First Approval:
None
UNII:
810U6C2DGG
Molecule Type:
Small molecule
Molecular Formula:
C7H6BClO2
Molecular Weight:
168.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ASTX-660
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma
Unknown
ASTX-660
×
Maximum Phase:
1
First Approval:
None
UNII:
2LHZ9ZC3YO
Molecule Type:
Small molecule
Molecular Formula:
C30H42FN5O3
Molecular Weight:
539.7
AlogP:
2.31
PSA:
81.17
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PF-03814735
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora-A inhibitor
PF-03814735
×
Maximum Phase:
1
First Approval:
None
UNII:
6V5T4O5758
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
122
123
124
125
126
127
128
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA